Eliquis Drug Interactions
Currently displaying 243 drugs known to have a moderate interaction with Eliquis (apixaban).
Moderate interactions with Eliquis (apixaban)
Note: Showing generic names only.
A
- abametapir topical
- abiraterone
- abrocitinib
- adalimumab
- alefacept
- alemtuzumab
- alpelisib
- aminoglutethimide
- amiodarone
- amlodipine
- amobarbital
- amprenavir
- anacaulase topical
- anakinra
- aprepitant
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atazanavir
- avacopan
B
- belzutifan
- bepridil
- berotralstat
- bexarotene
- bimekizumab
- bismuth subsalicylate
- bosentan
- brigatinib
- bromfenac ophthalmic
- butabarbital
- butalbital
C
- calaspargase pegol
- canakinumab
- capivasertib
- capmatinib
- celecoxib
- cenobamate
- ceritinib
- certolizumab
- chloramphenicol
- choline salicylate
- ciprofloxacin
- citalopram
- clarithromycin
- clomipramine
- clotrimazole
- coagulation factor x
- collagenase clostridium histolyticum
- crizotinib
- cyclosporine
D
- dabrafenib
- daclatasvir
- darunavir
- delavirdine
- deoxycholic acid
- desvenlafaxine
- dexamethasone
- dexfenfluramine
- diclofenac ophthalmic
- diclofenac topical
- diltiazem
- divalproex sodium
- dong quai
- dronedarone
- duloxetine
- duvelisib
E
- echinacea
- efavirenz
- elacestrant
- elagolix
- eliglustat
- elranatamab
- emapalumab
- encorafenib
- entrectinib
- epcoritamab
- erdafitinib
- erythromycin
- escitalopram
- eslicarbazepine
- etanercept
- etravirine
- ezogabine
F
- fedratinib
- felbamate
- felodipine
- fenfluramine
- fexinidazole
- flibanserin
- fluconazole
- fluoxetine
- flurbiprofen ophthalmic
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fostamatinib
- futibatinib
G
H
I
- icosapent
- idelalisib
- imatinib
- indinavir
- infliximab
- isavuconazonium
- istradefylline
- ivacaftor
- ivosidenib
- ixekizumab
K
L
- lapatinib
- larotrectinib
- lasmiditan
- lefamulin
- lenacapavir
- lesinurad
- letermovir
- levamlodipine
- levetiracetam
- levomilnacipran
- lomitapide
- lonapegsomatropin
- lorlatinib
M
- magnesium salicylate
- mavacamten
- mephobarbital
- miconazole
- midostaurin
- milnacipran
- mitapivat
- mitotane
- mosunetuzumab
N
- nafcillin
- nefazodone
- nepafenac ophthalmic
- neratinib
- nevirapine
- nifedipine
- nilotinib
- nintedanib
- niraparib
- nirogacestat
O
P
- pacritinib
- palbociclib
- paroxetine
- pazopanib
- pegaspargase
- pemigatinib
- pentobarbital
- pentosan polysulfate sodium
- pentoxifylline
- pexidartinib
- pirtobrutinib
- pralsetinib
- progesterone
- propafenone
- protein c
Q
R
- ranolazine
- repotrectinib
- ribociclib
- rifabutin
- rilonacept
- ripretinib
- ritlecitinib
- rofecoxib
- rolapitant
- ropeginterferon alfa-2b
- rucaparib
- rufinamide
S
- sarecycline
- sarilumab
- satralizumab
- secobarbital
- secukinumab
- selpercatinib
- selumetinib
- sertraline
- sibutramine
- siltuximab
- sodium iodide i-123
- sodium iodide-i-131
- sodium salicylate
- sodium thiosalicylate
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sorafenib
- sotorasib
- spironolactone
- stiripentol
- sugammadex
- sunitinib
- suprofen ophthalmic
- suvorexant
T
- tacrolimus
- tafasitamab
- talquetamab
- tamoxifen
- tebentafusp
- teclistamab
- telotristat
- tepotinib
- tocilizumab
- tolvaptan
- trofinetide
- troglitazone
- troleandomycin
- turmeric
U
V
- valdecoxib
- valproic acid
- vemurafenib
- venetoclax
- venlafaxine
- verapamil
- verteporfin
- vilazodone
- viloxazine
- vitamin e
- voclosporin
- vonoprazan
- vortioxetine
- voxelotor
Eliquis disease interactions
There are 4 disease interactions with Eliquis (apixaban) which include:
More about Eliquis (apixaban)
- Eliquis consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (224)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: factor Xa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.